Showing results (1361-1370 of 9,979) with videos related to

Sort By:
Pageof 998
Leukemia & Lymphoma|November 9, 2024
Improvement in quality of life in MDS patients who become transfusion independent after treatmentBo A Wan, Shabbir M H Alibhai, Lisa Chodirker, et al.
Leukemia & Lymphoma|November 14, 2024
When and how to transplant in myelofibrosis - recent trendsNaman Sharma, Giuseppe G Loscocco, Naseema Gangat, et al.
Leukemia & Lymphoma|October 8, 2024
Double hit lymphoma: contemporary understanding and practicesEashwar Somasundaram, Jeremy S Abramson
Leukemia & Lymphoma|October 14, 2024
HMA/VEN treatment modifications and associated outcomes in IDH-mutant AMLKuo-Kai Chin, Andriy Derkach, Christopher Famulare, et al.
Leukemia & Lymphoma|September 27, 2024
Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemiaKevin G Zablonski, Sydney A Skupa, Alexandria P Eiken, et al.
Leukemia & Lymphoma|October 1, 2024
Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphomaMazyar Shadman, Monika Salkar, Bhavini Srivastava, et al.
Leukemia & Lymphoma|September 13, 2024
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patientsÖzgür Mehtap, Tayfur Toptas, Mehmet S Dal, et al.
Leukemia & Lymphoma|September 23, 2024
Prognostic assessment value of immune escape-related genes in patients with acute myeloid leukemiaXiaohui Shangguan, Yanhong Huang, Congjie Chen, et al.
Leukemia & Lymphoma|October 25, 2024
Adoptive cell therapy in acute myeloid leukemia: the current landscape and emerging strategiesSerena Tharakan, Douglas Tremblay, Jacques Azzi
Leukemia & Lymphoma|September 11, 2024
The prognostic effect of blast count in TP53 mutant myeloid neoplasms -the Minnesota experienceMehrnoosh Tashakori, Sophia Yohe, Michael A Linden, et al.
Pageof 998